CureVac N.V. financial data

Symbol
CVAC on Nasdaq
Location
Tubingen
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 11 Apr 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 224,338,257 shares 0.16%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense €153,034,000 EUR 32%
General And Administrative Expense €69,690,000 EUR -24%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets €802,827,000 EUR 1.8%
Liabilities €106,219,000 EUR -61%